Skip to content

Clinical trials

Retinal Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Country / region: United States Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20054
20061
20081
20092
20103
20111
20121
20132
20141
20155
20162
20172
20186
20198
202011
20219
20224
202311
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Active, not recruiting19
Terminated15
Recruiting7
Unknown status5
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beacon Therapeutics7
Kodiak Sciences Inc7
Gyroscope Therapeutics Limited5
Nanoscope Therapeutics Inc.5
National Eye Institute (NEI)5
Gemini Therapeutics, Inc.3
AbbVie2
Adverum Biotechnologies, Inc.2
Editas Medicine, Inc.2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration83
Retinal Diseases43
Eye Diseases40
Macular Degeneration38
Retinitis Pigmentosa14
Geographic Atrophy11
Vision Disorders11
Retinal Dystrophies10
Wet Macular Degeneration10
Eye Diseases, Hereditary9

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.